Physiotherapy coupled with dextroamphetamine for rehabilitation after hemiparetic stroke: A randomized, double-blind, placebo-controlled trial

Stroke

Volumn 37, Issue 1, 2006, Pages 179-185

  Gladstone, David J ^a,b,c   Danells, Cynthia J ^c,d   Armesto, Armi ^a,b   McIlroy, William E ^a,b,c,d   Staines, W Richard ^a,b,c   Graham, Simon J ^a,b,c   Herrmann, Nathan ^a,d   Szalai, John P ^d   Black, Sandra E ^a,b,c  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HEART AND STROKE FOUNDATION OF CANADA   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Amphetamines; Physiotherapy; Randomized controlled trials; Rehabilitation

Indexed keywords

DEXAMPHETAMINE; PLACEBO; ADRENERGIC RECEPTOR STIMULATING AGENT;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ADULT; AGED; ANGINA PECTORIS; ARM MOVEMENT; ARTICLE; BRADYCARDIA; BRAIN CORTEX; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; CORTICALLY BASED STROKE; DAILY LIFE ACTIVITY; DEEP VEIN THROMBOSIS; DELIRIUM; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOCAL EPILEPSY; FUGL MEYER SCALE; GOUT; HAND FUNCTION; HEADACHE; HEMIPARESIS; HUMAN; INDEPENDENCE; LEG THROMBOSIS; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; MOTOR PERFORMANCE; PATIENT MOBILITY; PHYSIOTHERAPY; PNEUMONIA; PRESYNCOPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SINGLE DRUG DOSE; STROKE; SYNCOPE; TREATMENT RESPONSE; URINARY TRACT INFECTION; VISUAL HALLUCINATION; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; MIDDLE AGED; PARESIS; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

AGED; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; DEXTROAMPHETAMINE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PARESIS; PHYSICAL THERAPY MODALITIES; PLACEBOS; RECOVERY OF FUNCTION; SYMPATHOMIMETICS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33644875879     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000195169.42447.78     Document Type: Article

References (31)

1. Goldstein LB. Restorative Neurology: Advances in Pharmacotherapy for Recovery After Stroke. New York, NY: Futura Publishing; 1998.
2. Feeney DM, Gonzalez A, Law WA. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science. 1982;217:855-857.
3. Hovda DA, Fenney DM. Amphetamine with experience promotes recovery of locomotor function after unilateral frontal cortex injury in the cat. Brain Res. 1984;298:358-361.
4. Gladstone DJ, Black SE. Enhancing recovery after stroke with noradrenergic pharmacotherapy: a new frontier? Can J Neurol Sci. 2000;27:97-105.
5. Goldstein LB, Davis JN. Post-lesion practice and amphetamine-facilitated recovery of beam-walking in the rat. Restor Neurol Neurosci. 1990;2:311-314.
6. Goldstein LB. Pharmacology of recovery after stroke. Stroke. 1990;21:139-142.
7. Stroemer RP, Kent TA, Hulsebosch CE. Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats. Stroke. 1998;29:2381-2395.
8. Gold P, Delanoy R, Merrin J. Modulation of long-term potentiation by peripherally administered amphetamine and epinephrine. Brain Res. 1984;305:103-107.
9. Butefisch CM, Davis BC, Sawaki L, Waldvogel D, Classen J, Kopylev L, Cohen LG. Modulation of use-dependent plasticity by d-amphetamine. Ann Neurol. 2002;51:59-68.
10. Crisostomo EA, Duncan PW, Propst M, Dawson DV, Davis JN. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol. 1988;23:94-97.
11. Martinsson L, Wahlgren NG, Hårdemark H-G. Amphetamines for improving recovery after stroke (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.
12. Walker-Batson D, Smith P, Curtis S, Unwin H, Greenlee R. Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence. Stroke. 1995;26:2254-2259.
13. Volpe BT, Shelton F, Krebs HI, Hogan N, Diels C, Reding M. Dextro-amphetamine paired with standard and robotic neurorehabilitation changes motor performance one day later. Ann Neurol. 2000;48:454.
14. Martinsson L, Wahlgren NG. Safety of dexamphetamine in acute ischemic stroke: a randomized, double-blind, controlled dose-escalation trial. Stroke. 2003;34:475-481.
15. Reding M, Solomon B, Borucki SJ. Effect of dextroamphetamine on motor recovery after stroke. Neurology. 1995;45:A222 (Abstract).
16. Mazagri R, Shuaib A, McPehrson M, Deighton M. Amphetamine failed to improve motor function in acute stroke. Can J Neurol Sci. 1995;22:S25.
17. Vachalathiti R, Asavavallobh C, Nilanont Y, Poungvarin N. Comparison of physical therapy and physical therapy with amphetamine in sensorimotor recovery of acute stroke patients: randomized controlled trial. J Neurol Sci 2001;187(suppl 1):S253.
18. Sonde L, Nordstrom M, Nilsson CG, Lokk J, Viitanen M. A double-blind placebo-controlled study of the effects of amphetamine and physiotherapy after stroke. Cerebrovasc Dis. 2001;12:253-257.
19. Treig T, Werner C, Sachse M, Hesse S. No benefit from D-amphetamine when added to physiotherapy after stroke: a randomized, placebo-controlled study. Clin Rehabil. 2003;17:590-599.
20. Martinsson L, Eksborg S, Wahlgren NG. Intensive early physiotherapy combined with dexamphetamine treatment in severe stroke: a randomized, controlled pilot study. Cerebrovasc Dis. 2003;16:338-345.
21. Walker-Batson D, Curtis S, Natarajan R, Ford J, Dronkers N, Salmeron E, Lai J, Unwin DH. A double-bind, placebo-controlled study of the use of amphetamine in the treatment of aphasia. Stroke. 2001;32:2093-2098.
22. Fugl-Meyer AR, Jaasko L, Leyman I, Olsson S, Steglind S. The post-stroke hemiplegic patient. Scand J Rehabil Med. 1975;7:13-31.
23. Gladstone DJ, Danells CJ, Black SE. The Fugl-Meyer Assessment of motor recovery after stroke: a critical review of its measurement properties. Neurorehabil Neurol Repair. 2002;16:232-240.
24. Duncan PW, Goldstein LB, Matchar D, Divine GW, Feussner J. Measurement of motor recovery after stroke. Outcome assessment and sample size requirements. Stroke. 1992;23:1084-1089.
25. Keith RA, Granger CV, Hamilton BB, Sherwin FS. The Functional Independence Measure: a new tool for rehabilitation. Adv Clin Rehabil. 1987;1:6-18.
26. Gowland C, VanHullenaar S, Torresin W, et al. Chedoke-McMaster Stroke Assessment: Development, Validation and Administration Manual. Chedoke-McMaster Hospitals and McMaster University; 1995.
27. Seaby L, Torrance G. Reliability of a physiotherapy functional assessment used in a rehabilitation setting. Physiother Can. 1989;41:264-271.
28. Barreca S, Dobell H, O'Flaherty J. The Chedoke Arm and Hand Inventory: an evaluative measure. Physiother Can. 2000;52:S2.
29. Gladstone DJ, Black SE, Hakim AM. Towards wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke. 2002;33:2123-2136.
30. Parry RH, Lincoln NB, Vass CD. Effect of severity of arm impairment on response to additional physiotherapy early after stroke. Clin Rehabil. 1999;13:187-198.
31. Kwakkel G, Wagenaar RC, Twisk JWR, Lankhorst GJ, Koetsier JC. Intensity of leg and arm training after primary middle-cerebral-artery stroke: a randomised trial. Lancet. 1999;354:191-196.